Societal CDMO (formerly Recro) Revenue and Competitors
Estimated Revenue & Valuation
- Societal CDMO (formerly Recro)'s estimated annual revenue is currently $56.3M per year.
- Societal CDMO (formerly Recro)'s estimated revenue per employee is $201,000
Employee Data
- Societal CDMO (formerly Recro) has 280 Employees.
- Societal CDMO (formerly Recro) grew their employee count by -5% last year.
Societal CDMO (formerly Recro)'s People
Name | Title | Email/Phone |
---|---|---|
1 | VP - Innovation | Reveal Email/Phone |
2 | VP Finance | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | VP Operations & Site Head | Reveal Email/Phone |
5 | VP, Regulatory Affairs and Pharmacovigilance | Reveal Email/Phone |
6 | VP Tech Ops and Site Head | Reveal Email/Phone |
7 | VP Sales | Reveal Email/Phone |
8 | VP People, Culture and ESG | Reveal Email/Phone |
9 | VP Quality | Reveal Email/Phone |
10 | VP, Sales | Reveal Email/Phone |
Societal CDMO (formerly Recro) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Societal CDMO (formerly Recro)?
Societal CDMO is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services the global pharmaceutical market. In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, totaling 145,000 square feet, in Gainesville, Georgia, and San Diego, California.
keywords:N/AN/A
Total Funding
280
Number of Employees
$56.3M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $63.1M | 280 | 215% | N/A |
#2 | $78.5M | 281 | 19% | N/A |
#3 | $76.3M | 282 | 9% | N/A |
#4 | $76M | 282 | 8% | N/A |
#5 | $83.8M | 282 | 7% | N/A |